1 – 10 of 71
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Nephrotoxicity Surveillance for Childhood and Young Adult Survivors of Cancer : Recommendations From the International Late Effects of Childhood Cancer Guideline Harmonization Group
- Contribution to journal › Article
-
Mark
Pancreatic Adenocarcinoma : Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
- Contribution to journal › Article
- 2024
-
Mark
Cumulative Absolute Risk of Subsequent Colorectal Cancer After Abdominopelvic Radiotherapy Among Childhood Cancer Survivors : A PanCareSurFup Study
- Contribution to journal › Article
-
Mark
Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation
- Contribution to journal › Article
-
Mark
Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial
- Contribution to journal › Article
-
Mark
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results
- Contribution to journal › Article
- 2023
-
Mark
Risk Factors for Heart Failure among Pan-European Childhood Cancer Survivors : A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study
- Contribution to journal › Article
-
Mark
Chromosomal Gains as a Favorable Prognostic Factor in Pediatric ALL
- Contribution to journal › Article
-
Mark
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma with Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination
- Contribution to journal › Article
-
Mark
Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer
- Contribution to journal › Article
